Figure 3. Pupil size during and after the infusion of saline (open square), remifentanil (solid circle), and alfentanil (solid triangle). Targeted doses of remifentanil tested were 0.75 (LO), 1.5 (MED), and 3 (HI) ng/ml; targeted doses of alfentanil tested were 16 (LO), 32 (MED), and 64 (HI) ng/ml. Each infusion dose was tested for 40 min, and the total infusion period was 120 min, the a 3-h postinfusion period (recovery) ensued. Technical difficulties prevented us from using pictures from one of the participants; each symbol represents the mean response for nine participants. Asterisks above a symbol indicate that the rating is significantly different from the corresponding saline infusion rating. Brackets above or below symbols indicate SEM.

Figure 3. Pupil size during and after the infusion of saline (open square), remifentanil (solid circle), and alfentanil (solid triangle). Targeted doses of remifentanil tested were 0.75 (LO), 1.5 (MED), and 3 (HI) ng/ml; targeted doses of alfentanil tested were 16 (LO), 32 (MED), and 64 (HI) ng/ml. Each infusion dose was tested for 40 min, and the total infusion period was 120 min, the a 3-h postinfusion period (recovery) ensued. Technical difficulties prevented us from using pictures from one of the participants; each symbol represents the mean response for nine participants. Asterisks above a symbol indicate that the rating is significantly different from the corresponding saline infusion rating. Brackets above or below symbols indicate SEM.

Close Modal

or Create an Account

Close Modal
Close Modal